Market Cap 15.04B
Revenue (ttm) 29.05M
Net Income (ttm) -171.98M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -592.01%
Debt to Equity Ratio 0.00
Volume 4,255,100
Avg Vol 6,851,796
Day's Range N/A - N/A
Shares Out 695.49M
Stochastic %K 39%
Beta 1.22
Analysts Strong Sell
Price Target $27.00

Company Profile

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody that targets the neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythemat...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 20 7400 3347
Website: roivant.com
Address:
50 Broadway, 7th Floor, London, United Kingdom
DocPharm
DocPharm Feb. 3 at 12:39 AM
$ABUS $ABUS also remember the Canadian government banned Moderna from using ABUS/$ROIV /GENEVANT LNP, except for 4 indications … sars-covid was not one Fact: Moderna used the LNP in their phase 1 study - to the T Fact: Moderna used a black box on their phase 2 and 3 protocols - “It’s proprietary, trust me” “fib a little” Fact: Moderna tried invalidating all of our patents;most survived Fact: Moderna had a defense of , the government made “us” do it. Now they don’t.
3 · Reply
dixiebull
dixiebull Feb. 2 at 10:28 PM
$USAR swing from 22 ran to 26 then gave a pullback, going to be a roller coaster for awhile but day trade wise, see if 22 holds for 23 and 24 $ROIV may pull to 21.50 but if 22 can break again then 22.50 to 23 and maybe higher $SWVL see if 2 can hold with volume can run back to 2.50 and maybe 3 if it can break vwap $JLHL halter all morning, we can see where it is in the morning but if 4 holds it has a chance to give another run to 6.50 $PLTR rips on earnings, see if 150 holds for a move to 160 and 165
0 · Reply
5htc2
5htc2 Feb. 2 at 7:09 PM
$ROIV this is quite the dip and rip
1 · Reply
countingguy2006
countingguy2006 Feb. 2 at 12:32 PM
$ABUS $ROIV - Court trial: T-minus 35 days!
0 · Reply
DocPharm
DocPharm Jan. 30 at 5:02 PM
$ROIV adding
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 28 at 11:48 PM
$ROIV Share Price: $21.91 Contract Selected: May 15, 2026 $20 Calls Buy Zone: $2.29 – $2.84 Target Zone: $4.23 – $5.17 Potential Upside: 74% ROI Time to Expiration: 106 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
JFais
JFais Jan. 28 at 2:59 PM
$STTK (NP) $700MC (fully diluted), $550M EV (with warrants exercised) Running up into Q2 data for SL-325 (first DR3 blocking antibody in clinic) Big idea = they can achieve more potent & durable blockade vs competitors solely pursuing TL1A (Roche $ROIV $7B comp comes to mind)
0 · Reply
Quantumup
Quantumup Jan. 28 at 1:28 PM
Evercore ISI⬆️ $VRDN's PT to $45 from $44 and reiterated at an Outperform rating. $AMGN $IMVT - $ROIV $NVS TEVA Here's what Evercore ISI said in its note: https://x.com/Quantumup1/status/2016502597268471892?s=20
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 27 at 2:22 AM
$ROIV RSI: 66.67, MACD: 0.4036 Vol: 0.73, MA20: 22.40, MA50: 21.65 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
TrendEdgeLogan
TrendEdgeLogan Jan. 21 at 6:31 PM
$IMVT 5.3B mc $XBI / $IBB name also looking poised here as price sees accumulation at the 10-week SMA above a flat 80-week SMA and rising 40-week SMA - $ROIV is the top shareholder, owning over half of shares outstanding. As recently as December, they added 17M shares to their position, increasing their ownership by 17.24% - Short squeeze underway as short float % has steadily declined from 34.27% in June '25 to 21.16% today - Pct of all funds rose in the most recent qtr TrendEdge.app/asset/IMVT
0 · Reply
Latest News on ROIV
Roivant Sciences Ltd. (ROIV) Presents at 44th Annual J.P.

Jan 12, 2026, 10:15 PM EST - 21 days ago

Roivant Sciences Ltd. (ROIV) Presents at 44th Annual J.P.


Roivant Sciences Ltd. (ROIV) Q2 2025 Earnings Call Transcript

Jan 8, 2026, 10:42 AM EST - 26 days ago

Roivant Sciences Ltd. (ROIV) Q2 2025 Earnings Call Transcript


Roivant Sciences Ltd. (ROIV) Analyst/Investor Day Transcript

Dec 12, 2025, 6:12 PM EST - 7 weeks ago

Roivant Sciences Ltd. (ROIV) Analyst/Investor Day Transcript


Roivant Sciences: Brepocitinib And Roadmap Still Underpriced

Nov 13, 2025, 7:28 AM EST - 2 months ago

Roivant Sciences: Brepocitinib And Roadmap Still Underpriced


Roivant Sciences Ltd. (ROIV) Q2 2026 Earnings Call Transcript

Nov 10, 2025, 12:31 PM EST - 3 months ago

Roivant Sciences Ltd. (ROIV) Q2 2026 Earnings Call Transcript


Roivant Sciences Ltd. (ROIV) Q1 2024 Earnings Call Transcript

Sep 23, 2025, 5:45 AM EDT - 4 months ago

Roivant Sciences Ltd. (ROIV) Q1 2024 Earnings Call Transcript


Roivant Sciences Ltd. - Special Call

Sep 17, 2025, 3:43 PM EDT - 4 months ago

Roivant Sciences Ltd. - Special Call


Roivant Sciences Ltd. (ROIV) Q1 2025 Earnings Call Transcript

Aug 11, 2025, 12:28 PM EDT - 6 months ago

Roivant Sciences Ltd. (ROIV) Q1 2025 Earnings Call Transcript


Roivant Sciences Ltd. (ROIV) Q4 2024 Earnings Call Transcript

May 29, 2025, 2:17 PM EDT - 8 months ago

Roivant Sciences Ltd. (ROIV) Q4 2024 Earnings Call Transcript


Roivant Sciences: Primed For Growth With A De-Risked Pipeline

Apr 23, 2025, 12:13 PM EDT - 10 months ago

Roivant Sciences: Primed For Growth With A De-Risked Pipeline


Roivant Sciences Ltd. (ROIV) Q3 2024 Earnings Call Transcript

Feb 10, 2025, 12:32 PM EST - 1 year ago

Roivant Sciences Ltd. (ROIV) Q3 2024 Earnings Call Transcript


Roivant Sciences: A Biotech Growth Play With Major Ambitions

Dec 4, 2024, 8:30 AM EST - 1 year ago

Roivant Sciences: A Biotech Growth Play With Major Ambitions


Roivant's lung disease drug fails mid-stage trial

Dec 3, 2024, 7:19 AM EST - 1 year ago

Roivant's lung disease drug fails mid-stage trial


Roivant Sciences Ltd. (ROIV) Q2 2024 Earnings Call Transcript

Nov 12, 2024, 2:41 PM EST - 1 year ago

Roivant Sciences Ltd. (ROIV) Q2 2024 Earnings Call Transcript


DocPharm
DocPharm Feb. 3 at 12:39 AM
$ABUS $ABUS also remember the Canadian government banned Moderna from using ABUS/$ROIV /GENEVANT LNP, except for 4 indications … sars-covid was not one Fact: Moderna used the LNP in their phase 1 study - to the T Fact: Moderna used a black box on their phase 2 and 3 protocols - “It’s proprietary, trust me” “fib a little” Fact: Moderna tried invalidating all of our patents;most survived Fact: Moderna had a defense of , the government made “us” do it. Now they don’t.
3 · Reply
dixiebull
dixiebull Feb. 2 at 10:28 PM
$USAR swing from 22 ran to 26 then gave a pullback, going to be a roller coaster for awhile but day trade wise, see if 22 holds for 23 and 24 $ROIV may pull to 21.50 but if 22 can break again then 22.50 to 23 and maybe higher $SWVL see if 2 can hold with volume can run back to 2.50 and maybe 3 if it can break vwap $JLHL halter all morning, we can see where it is in the morning but if 4 holds it has a chance to give another run to 6.50 $PLTR rips on earnings, see if 150 holds for a move to 160 and 165
0 · Reply
5htc2
5htc2 Feb. 2 at 7:09 PM
$ROIV this is quite the dip and rip
1 · Reply
countingguy2006
countingguy2006 Feb. 2 at 12:32 PM
$ABUS $ROIV - Court trial: T-minus 35 days!
0 · Reply
DocPharm
DocPharm Jan. 30 at 5:02 PM
$ROIV adding
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 28 at 11:48 PM
$ROIV Share Price: $21.91 Contract Selected: May 15, 2026 $20 Calls Buy Zone: $2.29 – $2.84 Target Zone: $4.23 – $5.17 Potential Upside: 74% ROI Time to Expiration: 106 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
JFais
JFais Jan. 28 at 2:59 PM
$STTK (NP) $700MC (fully diluted), $550M EV (with warrants exercised) Running up into Q2 data for SL-325 (first DR3 blocking antibody in clinic) Big idea = they can achieve more potent & durable blockade vs competitors solely pursuing TL1A (Roche $ROIV $7B comp comes to mind)
0 · Reply
Quantumup
Quantumup Jan. 28 at 1:28 PM
Evercore ISI⬆️ $VRDN's PT to $45 from $44 and reiterated at an Outperform rating. $AMGN $IMVT - $ROIV $NVS TEVA Here's what Evercore ISI said in its note: https://x.com/Quantumup1/status/2016502597268471892?s=20
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 27 at 2:22 AM
$ROIV RSI: 66.67, MACD: 0.4036 Vol: 0.73, MA20: 22.40, MA50: 21.65 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
TrendEdgeLogan
TrendEdgeLogan Jan. 21 at 6:31 PM
$IMVT 5.3B mc $XBI / $IBB name also looking poised here as price sees accumulation at the 10-week SMA above a flat 80-week SMA and rising 40-week SMA - $ROIV is the top shareholder, owning over half of shares outstanding. As recently as December, they added 17M shares to their position, increasing their ownership by 17.24% - Short squeeze underway as short float % has steadily declined from 34.27% in June '25 to 21.16% today - Pct of all funds rose in the most recent qtr TrendEdge.app/asset/IMVT
0 · Reply
DocPharm
DocPharm Jan. 16 at 3:22 PM
$ROIV Adding just a few… News with $ABUS about added matter & the long weekend intrigue me
0 · Reply
sheepmanct
sheepmanct Jan. 16 at 3:05 PM
$ROIV If interested https://investor.arbutusbio.com/node/19421/html
1 · Reply
WAJeff
WAJeff Jan. 14 at 7:51 PM
$ROIV $23.76 52 week high
0 · Reply
DocPharm
DocPharm Jan. 13 at 4:55 PM
$ROIV the gem that keeps getting shinier ;)
0 · Reply
DocPharm
DocPharm Jan. 13 at 4:55 PM
$ABUS food for thought - Zero ABUS presentations to shareholders since the quiet period announcement Only presentation has been regarding Genevant at $ROIV R&D day Very little communication to SH since - Only those required by law Reminder $ROIV overhauled the Exec team and BoD last year
1 · Reply
J_Wayne
J_Wayne Jan. 13 at 4:43 PM
$ROIV interesting
1 · Reply
ccdemuth
ccdemuth Jan. 12 at 7:57 PM
$WLFC $CFNB $GDEN $LQDA $ROIV https://seekingalpha.com/article/4858893-chris-demuth-jr-shares-some-stock-picks
0 · Reply
Shortsales
Shortsales Jan. 6 at 10:25 PM
1 · Reply
MWM
MWM Dec. 31 at 7:43 PM
Calls on $ABUS and $ROIV and puts on $MRNA???
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 29 at 7:09 PM
$ROIV RSI: 55.57, MACD: 0.5996 Vol: 0.93, MA20: 21.58, MA50: 20.48 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
solidflo
solidflo Dec. 29 at 2:52 PM
$ABUS how much will we see if favorable judgement. Or does it majority go to $ROIV? Why is $ABUS so stale and why is $ROIV 10x when bought abus?
3 · Reply
GoingPrivateG
GoingPrivateG Dec. 25 at 7:40 AM
$ROIV The valuation debate now centers on reliability of delivery, where each milestone now functions as a credibility checkpoint. Any drift in timelines risks renewed volatility.
0 · Reply